Trypanosomiasis
Top View
- Medical Classifications
- The Selection and Use of Essential Medicines
- Entamoeba Histolytica/E
- The New Status of Parasitic Diseases in the COVID-19 Pandemic—Risk Factors Or Protective Agents?
- Tropical Cases
- Eloy LJ and Lucheis SB. Canine Trypanosomiasis: Etiology of Infection and Implications for Public Health
- Technical Appendix
- A Review on the Occurrence of Companion Vector-Borne Diseases in Pet Animals in Latin America
- Compounds from African Medicinal Plants with Activities Against Protozoal Diseases: Schistosomiasis, Trypanosomiasis and Leishmaniasis
- Instruction for Classifying the Underlying Cause of Death
- One Health Approach to Leishmaniases: Understanding the Disease Dynamics Through Diagnostic Tools
- About Trypanosoma Brucei Gambiense, the Causative Agent of the Chronic Form of Human African Trypanosomiasis: Some Findings and Proposals
- Trichomonas Vaginalis: Treatment Questions and Challenges
- Trypanosomiasis: Recent Advances in Strategies for Control
- Paenidigyamycin A, Potent Antiparasitic Imidazole Alkaloid from the Ghanaian Paenibacillus Sp
- Sleeping Sickness at the Crossroads
- A Complementary Herbal Product for Controlling Giardiasis
- Human African Trypanosomiasis, Chagas Disease and Leishmaniases